Decoding placental dysfunction with a new angiogenic classification of PlGF and sFlt-1

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Reproductive Biology

Background:

• The sFlt-1/PlGF ratio aids in managing hypertensive disorders of pregnancy and fetal growth restriction.
• Current ratio-based assessments have limitations in accurately stratifying maternal and fetal risk.
• Placental dysfunction requires improved diagnostic tools for timely intervention.

Purpose of the Study:

• To propose and validate a novel angiogenic classification system for placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1).
• To enhance the accuracy of maternal and fetal risk assessment in pregnancies with suspected placental dysfunction.
• To compare the proposed classification with the existing sFlt-1/PlGF ratio method.

Main Methods:

• Retrospective analysis of 227 hospitalized singleton pregnancies with hypertensive disorders and/or fetal growth restriction beyond 20 weeks.
• Classification based on sFlt-1/PlGF ratio categories (low, medium, high, very high).
• Development of a nine-category classification based on gestational age-specific PlGF and sFlt-1 levels relative to normal ranges.

Main Results:

• Categories 4 and 6 showed higher rates of fetal growth restriction.
• Categories 3 and 6 were associated with increased risk of severe maternal complications.
• Category 6 presented the highest risk of adverse maternal-fetal outcomes, while Category 1 had the lowest.
• 40% of patients deemed low/medium risk by sFlt-1/PlGF ratio were reclassified as high-risk by the new system.

Conclusions:

• Evaluating individual PlGF and sFlt-1 levels offers superior risk stratification compared to fixed ratio cut-offs.
• The proposed nine-category angiogenic classification improves identification of high-risk pregnancies.
• This novel approach enhances clinical management of placental pathology, leading to better maternal and fetal outcomes.